67 results
424B5
PCSA
Processa Pharmaceuticals Inc
28 May 24
Prospectus supplement for primary offering
4:49pm
and agents will not have any responsibility with respect to the validity or performance of these contracts.
To facilitate an offering of a series
8-K
EX-10.1
7wjw89b1dlczm7jw
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
rxwqy
29 Jan 24
Prospectus supplement with pricing info
4:15pm
8-K
EX-3.1
ac5rkm63mo1nonv
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
EX-10.1
05u570gn8uo
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
o1qshk2zl jnt6
24 Mar 22
Prospectus supplement for primary offering
4:15pm
PRE 14A
f0su m09rs
1 Sep 21
Preliminary proxy
4:46pm